hsa-mir-1294: Hsa-mir-1294 is a microRNA (miRNA) that has been studied in various contexts. In a study comparing epileptic children and controls, hsa-mir-1294 was found to have lower median TPM compared to hsa-miR-342-5p in discriminating epileptic children from healthy controls and drug-resistant epileptic children from drug-responsive epileptic children [PMC8866954]. Hsa-mir-1294 has also been implicated in the progression of oral squamous cell carcinoma [PMC8848895]. In another study, hsa-mir-1294 was predicted to target the genes ENO1 and circ-AMOTL1 [PMC7440838]. Additionally, hsa-mir-1294 was found to be involved in the regulation of several genes, including MAN2A2, TNFRSF12A, SPP1, CSNK1D, PLAUR, PFKFB3, and CXCL16 [PMC8836044]. Hsa-mir-1294 has also been associated with cognitive impairment progression [PMC9944228]. Furthermore, it has been identified as one of the potential miRNAs that interact with CXCL8 [PMC8923704]. Hsa-mir-1294 is one of the miRNAs with high expression log ratio in comparison to N-exo miRs in DMD-exo miRs [PMC7673361]. Lastly, it has been identified as one of the miRNAs associated with increased risk or decreased risk for certain conditions such as hepatocellular carcinoma and colorectal cancer [PMC8073146].